Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7410622 | 0.84 | ADAM17 (0.42) | HTTLMNAL3MBTL1KDM4CMAPT | |
| SCHEMBL7415161 | 0.81 | AGTR1 (0.53) | — | |
| SCHEMBL7415898 | 0.79 | AGTR1 (0.45) | KDM4C | |
| SCHEMBL7421726 | 0.78 | KDM4C (0.38) | LMNAKDM4C | |
| SCHEMBL12572410 | 0.74 | HTT (0.50) | NR1H4HTTCTDSP1LMNAL3MBTL1 | |
| SCHEMBL30524940 | 0.71 | LMNA (0.68) | HTTCTDSP1LMNAL3MBTL1MAPT | |
| SCHEMBL2005868 | 0.71 | LMNA (0.68) | HTTCTDSP1LMNAL3MBTL1MAPT | |
| SCHEMBL7420289 | 0.68 | KMT2A (0.37) | HTT | |
| SCHEMBL7418070 | 0.67 | ALDH1A1 (0.42) | LMNAMAPT | |
| SCHEMBL26607018 | 0.65 | GRM5 (0.46) | GRM5CNR1IMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993016071-A1 | HETEROCYCLIC DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-19 | — | — | WO | disclosed |